halothane has been researched along with 5,7-dihydroxytryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, A; Kalén, P; Rosengren, E; Strecker, RE | 1 |
| Bonhomme, N; De Deurwaerdère, P; Le Moal, M; Spampinato, U | 1 |
2 other study(ies) available for halothane and 5,7-dihydroxytryptamine
| Article | Year |
|---|---|
Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection.
Topics: 5,7-Dihydroxytryptamine; Anesthesia; Animals; Brain; Calcium; Caudate Nucleus; Chromatography, High Pressure Liquid; Denervation; Dialysis; Female; Halothane; Hydroxyindoleacetic Acid; Neurons; Piperidines; Potassium Chloride; Putamen; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tetrodotoxin | 1988 |
d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Anesthesia; Animals; Citalopram; Corpus Striatum; Dialysis; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fenfluramine; Halothane; Hydroxyindoleacetic Acid; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Serotonin; Tetrodotoxin | 1995 |